The purpose of this page is to list projects that are, or potentially might, submit data to ICDC
Possible submission status values:
- Identified - Possible submission but no contact with project owners
- Preliminary - Contact with project owners, discussions underway
- Declined - Project decided not to submit to ICDC
- Pre-approved - Project has submitted application to Data Governance Advisory Board
- Approved - DGAB has approved, awaiting submission
- Hold - no data is actively being submitted
- Submitting - Project is actively submitting data to ICDC
- Under Embargo - Submission done, awaiting final project approval for release
- Released - Data are available for public access
- Closed- No additional data will be submitted
| Project Name | Project Description | Project Leads | Project Institutions | Secondary Contact | Submission Status | Comments | Date for next action |
|---|---|---|---|---|---|---|---|
| Bladder/Mammary/Melanoma | Jonathan Levitt/Alan Herron | Baylor/U Florida/Texas A&M/Tech U Denmark | Anju Singh | Identified | P30 award | TBD | |
| B-cell lymphoma | Jill Slanksy/Steven Dow/Dawn Duval | U Colorado/Colorado State | Anju Singh | Identified | P30 award | Dawn to consult with CSU colleageagues | |
| Osteosarcoma | Katherine Janeway/Cheryl London | Dana Farber/Tufts | Anju Singh | Identified | P30 award | TBD | |
| Osteosarcoma | Separate from PRECINCT. | Dawn Duval | Colorado State | ||||
| Bladder (UBC02) | Deborah Knapp/Kim Lyerly | Purdue/Duke | Anju Singh | Submitting | P30 award | In process ICDC-1627 - Getting issue details... STATUS | |
| Glioma/Melanoma/Osteosarcoma | Arta Monjazeb | UC Davis | Anju Singh | Identified | P30 award | TBD | |
| Melanoma/Osteosarcoma | Peter Shields/Jefferey Trent | Ohio State/TGEN | Anju Singh | Identified | P30 award | TBD | |
| Glioma | Amy Heimberger/Jonathan Levine | MD Anderson/Texas A&M | Anju Singh | Identified | P30 award | TBD | |
| B-Cell lymphoma | Richard Koya/Kristy Richards | Roswell Park/Cornell | Anju Singh | Identified | P30 award, Kristy Richards passing is a significant setback. | TBD | |
| Osteosarcoma | Clinical information only from 165 dogs undergoing exactly the same treatment. Viewed as a comparator dataset. | Amy LeBlanc | NCI | Identified | TBD | ||
| Dogs Squared | Genomic Sequences | Amy LeBlanc | NCI | Identified | TBD | ||
| Meningioma | Companion to glioma study, 200 dogs from 11 vet schools
| Amy LeBlanc | NCI | Identified | TBD | ||
| Metastatic osteosarcoma | Reversal of Myeloid Cell Immune Suppression with A CCR2 Inhibitor Combined with a Myeloid Cell Depleting Agent for Treatment of Osteosarcoma Metastases | Steve Dow/Doug Thamm | Colorado State University | Identified | PRECINCT | TBD | |
| Diffuse large B cell lymphoma (DLBC) | Exploratory study of anti-CD20 plus RV1001 in dogs with DLBCL | Cheryl London | Tufts University | Identified | PRECINCT | TBD | |
| Malignant Glial brain tumors | Canine immuno neurotherapeutics | Melissa Renee Chambers | U Alabama at Birmingham | Identified | PRECINCT | TBD | |
| Metastatic osteosarcoma | Inhaled IL-15 immunotherapy for treatment of lung metastases | Robert Canter/Robert Rebhun | UC Davis | Identified | PRECINCT | TBD | |
| High grade glial brain tumors | Combined immunotherapeutic strategies for glioma | G. Elizabeth Pluhar | U Minnesota | Identified | PRECINCT | TBD | |
| Non-cancer | Whole genomes from 700 dogs in VCF format | Elaine Ostrander | NCI | Identified | Useful as a germline filter, not sure if it should be incorporated into IDCDC | TBD | |
| Zhaolab-CAN-14-0392 | Shaying Zhao | U Georgia | Submitting | TBD |
